BREAKING: The FDA agreed to conduct a review of its restrictions on mifepristone, a medication used for early abortion and miscarriage care.
After four years of litigation, this is long overdue, but a major move forward.
After four years of litigation, this is long overdue, but a major move forward.
Mifepristone is safe, effective, and has been FDA-approved for over 20 years.
Yet it remains subject to medically unnecessary restrictions that obstruct access and deepen health inequities for people of color, people with low incomes, and those in rural communities.
Yet it remains subject to medically unnecessary restrictions that obstruct access and deepen health inequities for people of color, people with low incomes, and those in rural communities.
Years of advocacy from medical experts, providers, patients, and advocates got us here.
We raised our voices and made a difference.
We raised our voices and made a difference.
Now, we'll be watching.
If the FDA follows the science, these harmful barriers to care will soon be gone for good.
If the FDA follows the science, these harmful barriers to care will soon be gone for good.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
